CELYAD ONCOLOGY (CLYYF:OTCMKTS)
$0.35 0 (0%)
Analysed CELYAD ONCOLOGY (CLYYF:OTCMKTS) News Sources
Celyad Oncology Reports Full Year 2025 Financial Results and Business Highlights
02-04-2026
yahoo.com
Celyad Oncology Announces the Sale of C-CATHez ® Catheter
12-02-2026
yahoo.com
Celyad Oncology: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
25-11-2025
yahoo.com
Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
14-11-2025
yahoo.com
Celyad Oncology Announces Research Facility Divestiture
29-09-2025
yahoo.com
Celyad Oncology Reports First Half Year 2025 Financial Results
25-09-2025
yahoo.com
Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
11-09-2025
yahoo.com
Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
04-09-2025
yahoo.com
Celyad Oncology Announces Discontinuation of R&D Activities
26-08-2025
yahoo.com
Celyad Oncology SA: Publication of a Transparency Notification Received from Fortress Investment Group LLC
13-08-2025
yahoo.com
What is the current price of CELYAD ONCOLOGY (CLYYF:OTCMKTS)?
The current price of CELYAD ONCOLOGY (CLYYF:OTCMKTS) is $0.35.
CELYAD ONCOLOGY (CLYYF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CELYAD ONCOLOGY (CLYYF:OTCMKTS) since the previous trading day is $0.
CELYAD ONCOLOGY (CLYYF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CELYAD ONCOLOGY (CLYYF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for CELYAD ONCOLOGY (CLYYF:OTCMKTS)?
The most recent average sentiment score for CELYAD ONCOLOGY (CLYYF:OTCMKTS) is 69 out of 100.
What is the most recent average sentiment for CELYAD ONCOLOGY (CLYYF:OTCMKTS)?
The most recent sentiment for CELYAD ONCOLOGY (CLYYF:OTCMKTS) is .
SEC-8K** Filing Available For CELYAD ONCOLOGY (CLYYF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.